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search for a new international treaty 
than the Bush administration.
Pachauri said there was still time 
for the developed countries to 
convince India and China to sign a 
new deal next year, but that it would 
require a series of “measures and 
actions” in the next few months.
He urged other rich countries 
to follow Europe’s lead and set 
ambitious carbon reduction targets 
for the next ten years. But some 
researchers now believe that these 
tough targets may not be enough 
to achieve the stable, manageable 
greenhouse gas sought by 
policymakers.
James Hansen, head of the Nasa 
Goddard Institute for Space Science 
in New York, believes the European 
goal of stabilising carbon dioxide 
levels at 550 parts per million in 
the atmospheres, may be still too 
high to avoid catastrophic climate 
change. Hansen has based his latest 
comments not on models, which 
have always attracted criticism 
from climate change detractors, 
but from historical evidence of 
previous atmospheric carbon dioxide 
concentrations measured from 
samples taken from the ocean floor.
Lord Stern, the economist whose 
report on climate change helped 
to galvanise world leaders behind 
the green energy movement when 
it was published 18 months ago, 
has admitted that the situation is 
far worse than the assumptions that 
formed the basis of his report.
“We badly underestimated the 
degree of damages and the risks of 
climate change,” he said in a speech 
in London last month. “All of the  
links in the chain are on average 
worse than we thought a couple  
of years ago.”
When it was first published, 
the Stern Review and its 
recommendations — zero emission 
cars around the world by 2050, for 
example — brought plaudits and 
brickbats from the different sides of 
the climate change debate. A year 
and a half on from its publication, 
Lord Stern dismissed the doubters 
and renewed his call for urgent 
global action. “People who said this 
was scaremongering are profoundly 
wrong. If anything, I was too reticent. 
What we are playing for is the 
transformation of the planet,” he said.
Greenhouse gas emissions are 
growing much faster than previously 
thought because of several factors 
that were not fully appreciated 
before, including the release of 
methane from thawing permafrost, 
the acidification of the oceans, 
and the decay of carbon sinks. 
The worsening situation increases 
the need, he argues, for a global 
pollution-cutting agreement to be 
reached by next year’s Copenhagen 
climate conference.
He also highlights the soaring use 
of coal for electricity generation, 
particularly in China where it is 
estimated a new coal-fired power 
station becomes operational each 
week at present. He believes such 
developments mean that the need 
to create effective carbon-capture 
technologies is urgent. “We need 
to get better at carbon capture and 
sequestration very quickly,” he said.
Coal is the most polluting fossil 
fuel, but it is also the major fuel for 
consumer nations that still have large 
reserves within their borders, and it is 
relatively cheap.
He also reiterated his previous 
estimates that governments 
and businesses must invest the 
equivalent of between one and two 
per cent of global GDP annually up 
to 2050 in new technologies and 
efficiency measures or face climate 
change of catastrophic proportions. A 
global carbon-trading system would 
be the “glue” for a worldwide climate 
deal, he said.A major international meeting on stem 
cell research was held in Edinburgh 
last month, flagging up Britain’s key 
role in this research because of a 
regulatory framework that makes 
some experiments on human embryos 
possible that are not allowed in many 
other countries. But the expansion of 
such research is beginning to grow 
elsewhere, and new techniques for 
creating useful stem cells without the 
use of embryos are emerging, so the 
announcement of new UK funds and 
public backing for the field has provided 
a welcome boost for researchers.
British researchers have already 
received the go-ahead to create 
animal–human embryos — where 
human genetic material is injected 
into an animal egg from which the 
nucleus has been removed — under 
current regulatory procedures 
determined by the Human Fertilisation 
and Embryology Authority (HFEA) 
but long-term approval is dependent 
on a current bill about to go through 
the British parliament. Researchers 
in two British groups have been 
pleased to be given the recent 
Public backing and new funds are 
helping to bolster Britain’s human 
embryo and stem cell research ahead 
of a key bill later this month.  
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debatego- ahead by the HFEA and are keen 
that the forthcoming bill will make 
future research possible. Stephen 
Minger, who leads one of the teams of 
embryonic stem researchers at King’s 
College London, said early this year 
that he was happy that the regulatory 
authority has finally realised the 
importance of “the work that we and 
the group from Newcastle have been 
licensed for”.
Unsurprisingly, the topic 
has been the subject of 
 considerable public debate 
but researchers will have 
been encouraged by a recent 
newspaper poll conducted by 
the Times
Lyle Armstrong, who leads the 
Newcastle group said: “Finding 
better ways to make human 
embryonic stem cells is the long-
term objective of our work and 
understanding reprogramming is 
central to this.”
Unsurprisingly, the topic has 
been the subject of considerable 
public debate but researchers will 
have been encouraged by a recent 
newspaper poll conducted by the 
Times.
The battle for public support 
over the creation of human–animal 
embryos has been won by scientists 
who want to use the controversial 
experiments to tackle diseases 
such as Alzheimer’s and Parkinson’s 
Magazine
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Times found that the hybrid embryo 
research won broad public approval, 
with 50 per cent backing new laws 
that would permit it and only  
30 per cent opposed.
The findings undermine claims by 
critics of the experiments that they 
enjoy little public support and they 
will bolster the government’s attempts 
to pass the new bill, which begins 
its passage through parliament in 
the House of Commons later this 
month. Government MPs have a free 
vote on the provisions that allow for 
human–animal embryos as announced 
by the prime minister, Gordon Brown, 
in March.
The newspaper poll, conducted 
at the beginning of last month, was 
the first to examine public opinion 
on hybrid embryos since Roman 
Catholic leaders made widely 
publicised attacks on the issue over 
Easter. Cardinal Keith O’Brien, head 
of the Catholic Church in Scotland, 
attacked the research as involving 
“experiments of Frankenstein 
proportion”, which he claimed had no 
public support.
But many researchers are feeling 
bullish. While the public focus is on 
the potential use of embryo- derived 
stem cells for research into 
debilitating diseases, another strand 
of work is looking at the potential of 
stem cells to create eggs and sperm.
An international group of scientists 
called the Hinxton Consortium 
has asked politicians not to block 
scientific enquiry into subjects such 
as stem cells and embryo research 
just because there is a difference of 
opinion on the ethics or morality  
of the work.
Considering research on the 
possible production of artificial eggs 
and sperm to treat infertile couples, 
the consortium said that moral 
disagreements in society should never 
be used on their own to stop scientific 
investigation.
Researchers are working on a 
number of ways of making stem cells 
derived from embryos, or ordinary 
tissue such as skin, and turning them 
in the laboratory into mature sperm 
and eggs that could then be used in 
IVF clinics for fertility treatment.
The Hinxton consortium, 
which was formed in 2006 to 
investigate the ethics and legality 
of stem cells, last month issued its 
recommendations for how research Relaxed: Half of Britons are supportive of proposed research on human embryos according to 
a recent poll. (Picture: Professors P.M. Motta and S. Makabe/Science Photo Library.)aimed at creating artificial gametes 
should proceed.
“Scientists have the authority to 
regulate science, and scientists 
have a responsibility to obey the 
law. However, policymakers should 
refrain from interfering with scientific 
enquiry unless there is a substantial 
justification for doing so that reaches 
beyond disagreements based solely 
on divergent moral convictions,” the 
consortium said.
Professor John Harris, a bioethicist 
at Manchester University and 
member of the consortium, said that, 
while the development of artificial 
sperm or eggs to treat infertile 
couples was still a long way off, it 
is important that the work is not 
blocked from the start.
The bill currently making its way 
through parliament would allow 
research into human artificial 
gametes but further changes to 
the law would be needed to allow 
doctors to use such sperm and eggs 
on patients.
Debra Mathews of Johns Hopkins 
University in Baltimore, a member of 
the Hinxton group, said that many 
people wanting to have their own 
biological children stand to benefit from ways of making artificial sperm 
and eggs in the laboratory. 
One possible way of making sperm 
and eggs would be to engineer them 
from skin cells, which raises the 
possibility that women could make 
sperm and men could make eggs, 
so that same-sex couples could 
have their own genetically related 
children.But these prospects at 
present seem remote. Robin Lovell-
Badge,head of the National Institute 
of Medical Research and a member 
of the group, said there may be major 
problems. “The group thought it 
was going to be very difficult to get 
eggs from an XY [male] chromosome 
individual and that it would be even 
more difficult, if not impossible, 
to get sperm from an XX [female] 
chromosome person.”
In the meantime, the Medical 
Research Council has announced 
new funding for stem cell research. 
The new funding is intended for 
“translational stem cell research” 
aimed at getting basic knowledge out 
of the lab and into patient care.
Researchers hope that this fillip 
and a favourable outcome for the 
new research bill will help bolster the 
country’s leading stem cell research.
